long intergenic non-protein coding RNA 2411Genealiases: []
Q-omics provides the consensus-scored LINC02411 profile across patient tissues and cancer cell-line models. LINC02411 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in READ. Among the 18 cancer types available for tumor–normal comparison, LINC02411 is differentially expressed in 3, with the highest sampling consensus in PRAD. Additionally, LINC02411 RNA expression shows 7,606 significant gene co-expression associations, with the highest sampling consensus in LGG. Together, these results highlight READ, PRAD, and LGG as cancer lineages where LINC02411 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02411 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02411 survival associations across molecular data types. LINC02411 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02411 RNA expression–survival associations across cancer types. High LINC02411 expression shows unfavorable associations in READ, LUSC, KIRP, UCEC, THCA and SKCM. The READ Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify READ as the clearest survival context for LINC02411 RNA expression.
This table summarizes LINC02411 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 3. The strongest signals are observed in PRAD for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02411. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02411 shows lower tumor expression in PRAD and ESCA and higher tumor expression in KIRC. The PRAD box plot shows higher LINC02411 RNA expression in normal versus tumor tissue (log2 FC = −0.006, t-test p = .019).
This table shows molecular features associated with LINC02411 in patient tissues and cancer cell lines. In patient samples, LINC02411 shows the broadest associations at the RNA and protein expression levels, with LGG recurring as the lineage with the largest associated feature set.
